[go: up one dir, main page]

WO2013057569A3 - Extended release pharmaceutical composition containing amoxicillin and clavulanic acid - Google Patents

Extended release pharmaceutical composition containing amoxicillin and clavulanic acid Download PDF

Info

Publication number
WO2013057569A3
WO2013057569A3 PCT/IB2012/002092 IB2012002092W WO2013057569A3 WO 2013057569 A3 WO2013057569 A3 WO 2013057569A3 IB 2012002092 W IB2012002092 W IB 2012002092W WO 2013057569 A3 WO2013057569 A3 WO 2013057569A3
Authority
WO
WIPO (PCT)
Prior art keywords
pharmaceutical composition
composition containing
extended release
clavulanic acid
release pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/IB2012/002092
Other languages
French (fr)
Other versions
WO2013057569A2 (en
Inventor
Rajesh Kshirsagar
Ganesh Shinde
Rashmi Ranjan PANDA
Dharmaraj Balasaheb MORE
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Micro Labs Ltd
Original Assignee
Micro Labs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Micro Labs Ltd filed Critical Micro Labs Ltd
Publication of WO2013057569A2 publication Critical patent/WO2013057569A2/en
Publication of WO2013057569A3 publication Critical patent/WO2013057569A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

An extended release pharmaceutical composition comprising amoxicillin and clavulanic acid or pharmaceutically acceptable salts thereof and a process for preparing thereof. The present invention particularly relates to composition containing various coatings in order to retard the release of the drug from tablet.
PCT/IB2012/002092 2011-10-19 2012-10-19 Extended release pharmaceutical composition containing amoxicillin and clavulanic acid Ceased WO2013057569A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN3591CH2011 2011-10-19
IN3591/CHE/2011 2011-10-19

Publications (2)

Publication Number Publication Date
WO2013057569A2 WO2013057569A2 (en) 2013-04-25
WO2013057569A3 true WO2013057569A3 (en) 2013-07-04

Family

ID=47178221

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IB2012/002092 Ceased WO2013057569A2 (en) 2011-10-19 2012-10-19 Extended release pharmaceutical composition containing amoxicillin and clavulanic acid

Country Status (1)

Country Link
WO (1) WO2013057569A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106084155B (en) * 2016-07-26 2018-06-08 中国科学院兰州化学物理研究所 The multistage pore polymer detached for oil water mixture and lotion without method for preparing template
WO2024102361A1 (en) * 2022-11-09 2024-05-16 Clarence Smith Kathleen E Pharmaceutical combination for the treatment of multiple myeloma, monoclonal gammopathy of undetermined significance, and smoldering multiple myeloma

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995028148A1 (en) * 1994-04-14 1995-10-26 Smithkline Beecham Plc Pharmaceutical formulation
WO2006009333A1 (en) * 2004-07-23 2006-01-26 Daewoong Pharmaceutical Co., Ltd. Cored tablets comprising clavulanate and amoxycilin with multiple film-coated core layer

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE208618T1 (en) 1995-09-07 2001-11-15 Smithkline Beecham Corp USE OF A PEDIATRIC PHARMACEUTICAL FORMULATION CONTAINING AMOXICILLIN AND CLAVULANATE
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995028148A1 (en) * 1994-04-14 1995-10-26 Smithkline Beecham Plc Pharmaceutical formulation
WO2006009333A1 (en) * 2004-07-23 2006-01-26 Daewoong Pharmaceutical Co., Ltd. Cored tablets comprising clavulanate and amoxycilin with multiple film-coated core layer

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
"Kollicoat Smartseal 30 D", June 2011 (2011-06-01), pages 1 - 15, XP002695541, Retrieved from the Internet <URL:http://www.pharma-ingredients.basf.com/Statements/Technical%20Informations/EN/Pharma%20Solutions/03_101002e_Kollicoat%20Smartseal%2030%20D.pdf> [retrieved on 20130416] *
LAURA PARTYNSKI: "BASF presents extensive portfolio of pharmaceutical ingredients and services at AAPS", 18 October 2011 (2011-10-18), pages 1 - 2, XP002695540, Retrieved from the Internet <URL:http://www.basf.com/group/corporate/us/en/news-and-media-relations/news-releases/news-releases-usa/P-10-0105> [retrieved on 20130416] *

Also Published As

Publication number Publication date
WO2013057569A2 (en) 2013-04-25

Similar Documents

Publication Publication Date Title
WO2011086531A3 (en) New anti-malarial agents
IL217052A0 (en) Nanostructured sildenafil base, its pharmaceutically acceptable salts and co-crystals, compositions of them, process for the preparation thereof and pharmaceutical compositions containing them
NZ705578A (en) Coated pharmaceutical composition containing regorafenib
WO2010092090A3 (en) Novel salts of sitagliptin
WO2011157721A3 (en) Ivabradine-containing pharmaceutical composition
WO2012010669A3 (en) Medicinal drug for oral administration comprising a mixture of silodosin and a basic copolymer
PH12014501408A1 (en) Immediate release multi unit pellet system
WO2011152809A3 (en) Effervescent formulations comprising cephalosporin and clavulanic acid
WO2014033526A9 (en) Pharmaceutical compositions of etoricoxib
SI3003383T1 (en) Solid composition for oral administration containing ibandronic acid or a pharmaceutically acceptable salt thereof and vitamin d
IL227024A (en) Amino-substituted 3-heteroaroylamino-propionic acid derivatives, process for the preparation of such compounds, uses thereof in the preparation of pharmaceuticals and pharmaceutical compositions comprising the same
WO2012074830A3 (en) Modified release tranexamic acid formulation
IN2015DN00280A (en)
WO2010012459A3 (en) A process for the preparation of solifenacin salts and their inclusion into pharmaceutical dosage forms
PH12015500395A1 (en) Pharmaceutical composite capsule formulation comprising irbesartan and hmg-coa reductase inhibitor
WO2013017910A8 (en) Extended release pharmaceutical compositions containing paliperidone
IL225105A (en) Heterocyclic compounds, process for their preparation, pharmaceutical compositions comprising them and use thereof for the preparation of medicaments
PL2291374T3 (en) Process for preparation of solifenacin and/or the pharmaceutically acceptable salts thereof of high pharmaceutical purity
WO2012014052A3 (en) Novel coated extended release pharmaceutical compositions containing paliperidone
WO2016091805A3 (en) Naloxone monopreparation and multi-layer tablet
EP2452678A3 (en) Pulsatile-release pharmaceutical formulation of dexlansoprazole
WO2013057569A3 (en) Extended release pharmaceutical composition containing amoxicillin and clavulanic acid
WO2014125504A3 (en) Pharmaceutical compositions of febuxostat
HU1000299D0 (en) Nanostructured atorvastatin, its pharmaceutically acceptable salts and pharmaceutical compositions containing them and process for their preparation
WO2011138797A3 (en) Delayed release oral disintegrating pharmaceutical compositions of lansoprazole

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12784678

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 12784678

Country of ref document: EP

Kind code of ref document: A2